English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

School of Pharmacy, Guangxi Medical University, Nanning, China; Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China Contributions: (I) Conception and design: M Dong; (II) Administrative support: M Dong; (III) Provision of study materials or patients: M Dong, B Xiang; (IV) Collection and assembly of data: Q Meng, J Tian, X Huang; (V) Data analysis and interpretation: F Qin, D Zhu; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Min Dong. School of Pharmacy, Guangxi Medical University, Nanning 530021, China. Email: dongmin0217@sina.com.

Protein tyrosine phosphatase receptor type delta (PTPRD) suppresses the expression of PD-L1 in human hepatocellular carcinoma by down-regulating STAT3